A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
Clinical trial NCT05059600 · COMPLETED
Trial details
- NCT number
- NCT05059600
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2022-07-14
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.